Dr Ronald Castelino

Dr Ronald Castelino

M02C - 88 Mallett Street - Building C
The University of Sydney

Telephone +61 2 9351 0609

Biographical details

Ronald Castelino is a Senior Lecturer in Pharmacology & Clinical Pharmacy at Sydney Nursing School and an Adjunct Senior Lecturer at the School of Medicine, University of Tasmania. He is a renal pharmacist (Blacktown Hospital) with a track record in translational research relevant to renal medicine. He also has a range of other interests which share a common focus on improving medication safety. He is an experienced academic and research degree supervisor having worked previously at the School of Medicine, University of Tasmania (2011-2016). He is currently involved in the coordination and delivery of Introduction to Pharmacology (Bachelor of Nursing) and Understanding Health and Managing Disease (Master of Nursing). He is also involved in teaching into postgraduate nursing units; The Body, its Function and Pharmacology (Master of Nursing); Quality Use of Medicines and Pharmacology for Advanced Practice (Nurse Practitioner)

Research interests

Dr Castelino’s work aligns with the theme: chronic disease and ageing, and health care practice. His main research interests are in the area of chronic disease state management especially kidney disease and health services research such as medication reviews. His current projects inlcude screening for chronic kidney disease in the community and quality use of medicines in patients with kidney disease. He is skilled in establishing internal and external working collaborations andhas a range of other interests which share a common focus on improving medication safety.

Teaching and supervision

Ronald Castelino’s teaching career includes therapeutics and disease state management as well as evidence-based practice). He is currently involved in the coordination & delivery of Introduction to Pharmacology (Bachelor of Nursing) and Understanding Health and Managing Disease (Master of Nursing). He is also involved in teaching into postgraduate nursing units; The Body, its Function and Pharmacology (Master of Nursing); Quality Use of Medicines and Pharmacology for Advanced Practice (Nurse Practitioner).

He has been involved in teaching therapeutics to 3rd & 4th year Bachelor of Pharmacy students, Evidence-based Health Care to 2nd Year Pharmacy students, clinical education of 3rd and 4th year pharmacy students, conducting clinical teaching rounds at the Royal Hobart Hospital, Year 4 Bachelor of Pharmacy Coordination and the undergraduate medicine program Functional Clinical Practice at the School of Medicine, University of Tasmania.

Dr Castelino has supervised PhD (1) and Honours (7) students to completion. He currently supervises PhD (4) and Honours (2) at the University of Tasmania. He has also been a member of the Tasmanian Scientific Research Advisory Committee (TSRAC) for over 2 years.

Current Students

Implementation of a Pharmacist Medication Review Clinic for Renal Disease Patients (PhD, University of Tasmania)

Community Pharmacy Screening and Medication Management in Chronic Kidney Disease (PhD, University of Tasmania)

Role of Medication Regimen Complexity in determining concordance to prescribed medications, and use of Complementary and Alternative medications in Chronic Kidney Disease patients (PhD, University of Tasmania)

Prescribing in patients hospitalised with kidney disease (PhD, University of Tasmania)

Current research students

Project title Research student
Screening for kidney disease in community pharmacies Linda KORIA
Improving the reporting of adverse drug reactions by healthcare professionals in Australia Raymond LI

Associations

Registered Pharmacist with Pharmacy Board of Australia

Pharmaceutical Society of Australia

Member of American College of Clinical Pharmacy

Member of American Society of Consultant Pharmacists

Society of Hospital Pharmacists of Australia

Awards and honours

Teaching Merit Certificates in recognition of teaching excellence (University of Tasmania, 2013 & 2014)

Keywords

Kidney disease; Medication Reviews

Selected grants

2019

  • Transforming medication safety in medicine and health curricula; Charles (nee Slaviero) K, Schneider C, Hilmer S, Buckley N, Lambert T, Castelino R, Mckay D, Moles R, Anderson J, Randal N, Ray A; DVC Education/Small Educational Innovation Grant.

2018

  • Authentic learning through the co-design of an e-medication management sandbox; Penm J, Poon S, Hilmer S, Castelino R, Schneider C, Moles R, Haq I; DVC Education/Large Educational Innovation Grant.

2016

  • Investigating the physical and chemical Y-site incompatibility of injectable antifungals and parenteral nutrition solution; Castelino R; Royal Hobart Hospital Research Foundation/2016 Starter Grants.

2015

  • Point of care creatinine testing to screen for chronic kidney disease; Castelino R; University of Tasmania/Research Enhancement Grants Scheme (REGS).

2014

  • Impact of community pharmacy services on screening for chronic kidney disease; Castelino R; Tasmanian Community Fund/Research Support.

Selected publications

Download citations: PDF RTF Endnote

Journals

  • Ghimire, S., Lee, K., Jose, M., Castelino, R., Zaidi, S. (2019). Adherence assessment practices in haemodialysis settings: A qualitative exploration of nurses and pharmacists' perspectives. Journal of Clinical Nursing, 28, 2197-2205. [More Information]
  • Khanam, M., Kitsos, A., Stankovich, J., Castelino, R., Jose, M., Peterson, G., Wimmer, B., Zaidi, T., Radford, J. (2019). Association of continuity of care with blood pressure control in patients with chronic kidney disease and hypertension. Australian Journal of General Practice, 48(5), 300-306.
  • Gheewala, P., Peterson, G., Zaidi, S., Jose, M., Castelino, R. (2019). Evaluation of a chronic kidney disease risk assessment service in community pharmacies. Nephrology, 24(3), 301-307. [More Information]
  • Ghimire, S., Banks, C., Jose, M., Castelino, R., Zaidi, S. (2019). Medication adherence assessment practices in dialysis settings: A survey of renal nurses� perceptions. Journal of Clinical Nursing, 28(3-Apr), 528-537. [More Information]
  • Tesfaye, W., Peterson, G., Castelino, R., McKercher, C., Jose, M., Wimmer, B., Zaidi, S. (2019). Medication Regimen Complexity and Hospital Readmission in Older Adults With Chronic Kidney Disease. Annals of Pharmacotherapy, 53(1), 28-34. [More Information]
  • Tesfaye, W., Peterson, G., Castelino, R., McKercher, C., Jose, M., Zaidi, S., Wimmer, B. (2019). Medication-Related Factors and Hospital Readmission in Older Adults with Chronic Kidney Disease. Journal of Clinical Medicine, 8(3), 1-12. [More Information]
  • Gheewala, P., Peterson, G., Zaidi, S., Jose, M., Castelino, R. (2018). Australian Community Pharmacists' Experience of Implementing a Chronic Kidney Disease Risk Assessment Service. Preventing Chronic Disease, 15, 1-9. [More Information]
  • Gheewala, P., Zaidi, S., Jose, M., Bereznicki, L., Peterson, G., Castelino, R. (2018). Effectiveness of targeted screening for chronic kidney disease in the community setting: a systematic review. Journal of Nephrology, 31(1), 27-36. [More Information]
  • Koria, L., Zaidi, T., Peterson, G., Nishtala, P., Hannah, P., Castelino, R. (2018). Impact of medication reviews on inappropriate prescribing in aged care. Current Medical Research and Opinion, 34(5), 833-838. [More Information]
  • Gheewala, P., Peterson, G., Zaidi, S., Jose, M., Castelino, R. (2018). Patient satisfaction with a chronic kidney disease risk assessment service in community pharmacies. International Journal of Clinical Pharmacy, 40(2), 458-463. [More Information]
  • Gheewala, P., Peterson, G., Zaidi, S., Jose, M., Castelino, R. (2018). Public knowledge of chronic kidney disease evaluated using a validated questionnaire: a cross-sectional study. BMC Public Health, 18(1), 371. [More Information]
  • Ghimire, S., Banks, C., Jose, M., Castelino, R., Zaidi, S. (2018). Renal pharmacists� perceptions and current practices of assessing medication adherence in dialysis patients. International Journal of Clinical Pharmacy, 40(1), 26-35. [More Information]
  • Kandel, S., Zaidi, S., Troy Wanandy, S., Ming, L., Castelino, R., Sud, K., Patel, R. (2018). STABILITY OF CEFTAZIDIME AND HEPARIN IN FOUR DIFFERENT TYPES OF PERITONEAL DIALYSIS SOLUTIONS. Peritoneal Dialysis International, 38(1), 49-56. [More Information]
  • Mendes, K., Harmanjeet, H., Sadeeq, M., Modi, A., Wanandy, T., Zaidi, S., Castelino, R., Sud, K., Peterson, G., Patel, R. (2018). Stability of meropenem and piperacillin/tazobactam with heparin in various peritoneal dialysis solutions. Peritoneal Dialysis International, 38(6), 430-440. [More Information]
  • Pouranayatihosseinabad, M., Zaidi, S., Peterson, G., Nishtala, P., Hannan, P., Castelino, R. (2018). The impact of residential medication management reviews (RMMRs) on medication regimen complexity. Postgraduate Medicine, 130(6), 575-579. [More Information]
  • Frain, B., Castelino, R., Bereznicki, L. (2018). The Utilization of Antithrombotic Therapy in Older Patients in Aged Care Facilities With Atrial Fibrillation. Clinical and Applied Thrombosis/Hemostasis, 24(3), 519-524. [More Information]
  • Khanal, A., Peterson, G., Jose, M., Castelino, R. (2017). Comparison of equations for dosing of medications in renal impairment. Nephrology, 22(6), 470-477. [More Information]
  • Tesfaye, W., Castelino, R., Wimmer, B., Zaidi, S. (2017). Inappropriate prescribing in chronic kidney disease: A systematic review of prevalence, associated clinical outcomes and impact of interventions. International Journal of Clinical Practice, 71(7), 1-16. [More Information]
  • Huang, W., Castelino, R., Peterson, G. (2017). Lactate Levels with Chronic Metformin Use: A Narrative Review. Clinical Drug Investigation, 37(11), 991-1007. [More Information]
  • Ghimire, S., Castelino, R., Jose, M., Zaidi, S. (2017). Medication adherence perspectives in haemodialysis patients: a qualitative study. BMC Nephrology, 18(1), 1-9. [More Information]
  • Frain, B., Castelino, R., Bereznicki, L. (2017). The Utilization of Antithrombotic Therapy in Older Australians With Atrial Fibrillation. Clinical and Applied Thrombosis/Hemostasis, 23(6), 671-676. [More Information]
  • Gheewala, P., Peterson, G., Zaidi, S., Bereznicki, L., Jose, M., Castelino, R. (2016). A web-based training program to support chronic kidney disease screening by community pharmacists. International Journal of Clinical Pharmacy, 38(5), 1080-1086. [More Information]
  • Nair, N., Chalmers, L., Peterson, G., Bereznicki, B., Castelino, R., Bereznicki, L. (2016). Hospitalization in older patients due to adverse drug reactions - The need for a prediction tool. Clinical Interventions in Aging, 11, 497-505. [More Information]
  • McLarin, P., Peterson, G., Curtain, C., Nishtala, P., Hannan, P., Castelino, R. (2016). Impact of residential medication management reviews on anticholinergic burden in aged care residents. Current Medical Research and Opinion, 32(1), 123-131. [More Information]
  • Huang, W., Castelino, R., Peterson, G. (2016). Lactic acidosis and the relationship with metformin usage: Case reports. Medicine, 95(46), 1-5. [More Information]
  • Bernal, D., Bereznicki, L., Chalmers, L., Castelino, R., Thompson, A., Davidson, P., Peterson, G. (2016). Medication Adherence Following Acute Coronary Syndrome: Does One Size Fit All? American Journal of Cardiovascular Drugs, 16(1), 9-17. [More Information]
  • Ghimire, S., Peterson, G., Castelino, R., Jose, M., Zaidi, S. (2016). Medication Regimen Complexity and Adherence in Haemodialysis Patients: An Exploratory Study. American Journal of Nephrology, 43(5), 318-324. [More Information]
  • Peterson, G., Huang, W., Castelino, R. (2016). Metformin: an old drug with clinical value and safety in old patients. Australian Pharmacist, July, 36-38.
  • Castelino, R., Peterson, G. (2016). Prescribing of metformin based on estimated GFR rather than serum creatinine expands the eligible population and is likely safe. Evidence-Based Medicine, 21(2), 68-68. [More Information]
  • Nishtala, P., Castelino, R., Peterson, G., Hannan, P., Salahudeen, M. (2016). Residential medication management reviews of antithrombotic therapy in aged care residents with atrial fibrillation: Assessment of stroke and bleeding risk. Journal Of Clinical Pharmacy And Therapeutics, 41(3), 279-284. [More Information]
  • Robiyanto, R., Zaidi, S., Shastri, M., Castelino, R., Troy Wanandy, S., Jose, M., Patel, R. (2016). Stability of tigecycline in different types of peritoneal dialysis solutions. Peritoneal Dialysis International, 36(4), 410-414. [More Information]
  • Huang, W., Castelino, R., Peterson, G. (2015). Adverse event notifications implicating metformin with lactic acidosis in Australia. Journal of Diabetes and Its Complications, 29(8), 1261-1265. [More Information]
  • Huang, W., Peterson, G., Zaidi, S., Castelino, R. (2015). Metformin utilisation in Australian community and aged care settings. Diabetes Research and Clinical Practice, 108(2), 336-341. [More Information]
  • Ghimire, S., Castelino, R., Lioufas, N., Peterson, G., Zaidi, S. (2015). Nonadherence to medication therapy in haemodialysis patients: A systematic review. PloS One, 10(12), 1-19. [More Information]
  • Khanal, A., Peterson, G., Castelino, R., Jose, M. (2015). Potentially Inappropriate Prescribing of Renally Cleared Drugs in Elderly Patients in Community and Aged Care Settings. Drugs and Aging, 32(5), 391-400. [More Information]
  • Doody, H., Peterson, G., Watson, D., Castelino, R. (2015). Retrospective evaluation of potentially inappropriate prescribing in hospitalized patients with renal impairment. Current Medical Research and Opinion, 31(3), 525-535. [More Information]
  • Bernal, D., Chalmers, L., Bereznicki, L., Castelino, R., Davidson, P., Peterson, G. (2014). An online person-centered education package for pharmacists delivering a home medication review service to patients following acute coronary syndromes. European Journal for Person Centered Healthcare, 2(3), 408-415. [More Information]
  • Khanal, A., Castelino, R., Peterson, G., Jose, M. (2014). Dose adjustment guidelines for medications in patients with renal impairment: How consistent are drug information sources? Internal Medicine Journal, 44(1), 77-85. [More Information]
  • Gheewala, P., Peterson, G., Curtain, C., Nishtala, P., Hannan, P., Castelino, R. (2014). Impact of the Pharmacist Medication Review Services on Drug-Related Problems and Potentially Inappropriate Prescribing of Renally Cleared Medications in Residents of Aged Care Facilities. Drugs and Aging, 31(11), 825-835. [More Information]
  • Huang, W., Castelino, R., Peterson, G. (2014). Metformin usage in type 2 diabetes mellitus: Are safety guidelines adhered to? Internal Medicine Journal, 44(3), 266-272. [More Information]
  • Khanal, A., Peterson, G., Castelino, R., Jose, M. (2014). Renal drug dosing recommendations: Evaluation of product information for brands of the same drug. Internal Medicine Journal, 44(6), 591-596. [More Information]
  • Castelino, R., Bereznicki, L. (2013). How to read and interpret clinical trials (part 2). Australian Pharmacist, 32(10), 68-69.
  • Castelino, R., Bereznicki, L. (2013). The basics of evidence-based medicine. Australian Pharmacist, 32(2), 72-74.
  • Castelino, R., Bereznicki, L. (2013). Understanding non-randomised study designs. Australian Pharmacist, 32(6), 63-64.
  • Bereznicki, L., Castelino, R. (2013). Understanding randomised controlled trials. Australian Pharmacist, 32(4), 71-72.
  • Bereznicki, L., Castelino, R. (2013). Understanding systematic reviews. Australian Pharmacist, 32(8), 68-69.
  • Bernal, D., Stafford, L., Bereznicki, L., Castelino, R., Davidson, P., Peterson, G. (2012). Home medicines reviews following acute coronary syndrome: Study protocol for a randomized controlled trial. Trials, 13(30), 1-17. [More Information]
  • Castelino, R., Bajorek, B., Chen, T. (2011). Are interventions recommended by pharmacists during Home Medicines Review evidence-based? Journal of Evaluation in Clinical Practice, 17(1), 104-110. [More Information]
  • Castelino, R., Sathvik, B., Parthasarathi, G., Gurudev, K., Shetty, M., Narahari, M. (2011). Prevalence of medication-related problems among patients with renal compromise in an Indian hospital. Journal Of Clinical Pharmacy And Therapeutics, 36(4), 481-487. [More Information]
  • Castelino, R., Hilmer, S., Bajorek, B., Nishtala, S., Chen, T. (2010). Drug Burden Index and potentially inappropriate medications in community-dwelling older people: the impact of Home Medicines Review. Drugs and Aging, 27(2), 135-148. [More Information]
  • Castelino, R., Bajorek, B., Chen, T. (2010). Retrospective Evaluation of Home Medicines Review by Pharmacists in Older Australian Patients Using the Medication Appropriateness Index. The Annals of Pharmacotherapy, 44(12), 1922-1929. [More Information]
  • Castelino, R., Chen, T., Guddattu, V., Bajorek, B. (2010). Use of evidence-based therapy for the prevention of cardiovascular events among older people. Evaluation and the Health Professions, 33(3), 276-301. [More Information]
  • Castelino, R., Bajorek, B., Chen, T. (2009). Targeting Suboptimal Prescribing in the Elderly: A Review of the Impact of Pharmacy Services. The Annals of Pharmacotherapy, 43(6), 1096-1106. [More Information]

2019

  • Ghimire, S., Lee, K., Jose, M., Castelino, R., Zaidi, S. (2019). Adherence assessment practices in haemodialysis settings: A qualitative exploration of nurses and pharmacists' perspectives. Journal of Clinical Nursing, 28, 2197-2205. [More Information]
  • Khanam, M., Kitsos, A., Stankovich, J., Castelino, R., Jose, M., Peterson, G., Wimmer, B., Zaidi, T., Radford, J. (2019). Association of continuity of care with blood pressure control in patients with chronic kidney disease and hypertension. Australian Journal of General Practice, 48(5), 300-306.
  • Gheewala, P., Peterson, G., Zaidi, S., Jose, M., Castelino, R. (2019). Evaluation of a chronic kidney disease risk assessment service in community pharmacies. Nephrology, 24(3), 301-307. [More Information]
  • Ghimire, S., Banks, C., Jose, M., Castelino, R., Zaidi, S. (2019). Medication adherence assessment practices in dialysis settings: A survey of renal nurses� perceptions. Journal of Clinical Nursing, 28(3-Apr), 528-537. [More Information]
  • Tesfaye, W., Peterson, G., Castelino, R., McKercher, C., Jose, M., Wimmer, B., Zaidi, S. (2019). Medication Regimen Complexity and Hospital Readmission in Older Adults With Chronic Kidney Disease. Annals of Pharmacotherapy, 53(1), 28-34. [More Information]
  • Tesfaye, W., Peterson, G., Castelino, R., McKercher, C., Jose, M., Zaidi, S., Wimmer, B. (2019). Medication-Related Factors and Hospital Readmission in Older Adults with Chronic Kidney Disease. Journal of Clinical Medicine, 8(3), 1-12. [More Information]

2018

  • Gheewala, P., Peterson, G., Zaidi, S., Jose, M., Castelino, R. (2018). Australian Community Pharmacists' Experience of Implementing a Chronic Kidney Disease Risk Assessment Service. Preventing Chronic Disease, 15, 1-9. [More Information]
  • Gheewala, P., Zaidi, S., Jose, M., Bereznicki, L., Peterson, G., Castelino, R. (2018). Effectiveness of targeted screening for chronic kidney disease in the community setting: a systematic review. Journal of Nephrology, 31(1), 27-36. [More Information]
  • Koria, L., Zaidi, T., Peterson, G., Nishtala, P., Hannah, P., Castelino, R. (2018). Impact of medication reviews on inappropriate prescribing in aged care. Current Medical Research and Opinion, 34(5), 833-838. [More Information]
  • Gheewala, P., Peterson, G., Zaidi, S., Jose, M., Castelino, R. (2018). Patient satisfaction with a chronic kidney disease risk assessment service in community pharmacies. International Journal of Clinical Pharmacy, 40(2), 458-463. [More Information]
  • Gheewala, P., Peterson, G., Zaidi, S., Jose, M., Castelino, R. (2018). Public knowledge of chronic kidney disease evaluated using a validated questionnaire: a cross-sectional study. BMC Public Health, 18(1), 371. [More Information]
  • Ghimire, S., Banks, C., Jose, M., Castelino, R., Zaidi, S. (2018). Renal pharmacists� perceptions and current practices of assessing medication adherence in dialysis patients. International Journal of Clinical Pharmacy, 40(1), 26-35. [More Information]
  • Kandel, S., Zaidi, S., Troy Wanandy, S., Ming, L., Castelino, R., Sud, K., Patel, R. (2018). STABILITY OF CEFTAZIDIME AND HEPARIN IN FOUR DIFFERENT TYPES OF PERITONEAL DIALYSIS SOLUTIONS. Peritoneal Dialysis International, 38(1), 49-56. [More Information]
  • Mendes, K., Harmanjeet, H., Sadeeq, M., Modi, A., Wanandy, T., Zaidi, S., Castelino, R., Sud, K., Peterson, G., Patel, R. (2018). Stability of meropenem and piperacillin/tazobactam with heparin in various peritoneal dialysis solutions. Peritoneal Dialysis International, 38(6), 430-440. [More Information]
  • Pouranayatihosseinabad, M., Zaidi, S., Peterson, G., Nishtala, P., Hannan, P., Castelino, R. (2018). The impact of residential medication management reviews (RMMRs) on medication regimen complexity. Postgraduate Medicine, 130(6), 575-579. [More Information]
  • Frain, B., Castelino, R., Bereznicki, L. (2018). The Utilization of Antithrombotic Therapy in Older Patients in Aged Care Facilities With Atrial Fibrillation. Clinical and Applied Thrombosis/Hemostasis, 24(3), 519-524. [More Information]

2017

  • Khanal, A., Peterson, G., Jose, M., Castelino, R. (2017). Comparison of equations for dosing of medications in renal impairment. Nephrology, 22(6), 470-477. [More Information]
  • Tesfaye, W., Castelino, R., Wimmer, B., Zaidi, S. (2017). Inappropriate prescribing in chronic kidney disease: A systematic review of prevalence, associated clinical outcomes and impact of interventions. International Journal of Clinical Practice, 71(7), 1-16. [More Information]
  • Huang, W., Castelino, R., Peterson, G. (2017). Lactate Levels with Chronic Metformin Use: A Narrative Review. Clinical Drug Investigation, 37(11), 991-1007. [More Information]
  • Ghimire, S., Castelino, R., Jose, M., Zaidi, S. (2017). Medication adherence perspectives in haemodialysis patients: a qualitative study. BMC Nephrology, 18(1), 1-9. [More Information]
  • Frain, B., Castelino, R., Bereznicki, L. (2017). The Utilization of Antithrombotic Therapy in Older Australians With Atrial Fibrillation. Clinical and Applied Thrombosis/Hemostasis, 23(6), 671-676. [More Information]

2016

  • Gheewala, P., Peterson, G., Zaidi, S., Bereznicki, L., Jose, M., Castelino, R. (2016). A web-based training program to support chronic kidney disease screening by community pharmacists. International Journal of Clinical Pharmacy, 38(5), 1080-1086. [More Information]
  • Nair, N., Chalmers, L., Peterson, G., Bereznicki, B., Castelino, R., Bereznicki, L. (2016). Hospitalization in older patients due to adverse drug reactions - The need for a prediction tool. Clinical Interventions in Aging, 11, 497-505. [More Information]
  • McLarin, P., Peterson, G., Curtain, C., Nishtala, P., Hannan, P., Castelino, R. (2016). Impact of residential medication management reviews on anticholinergic burden in aged care residents. Current Medical Research and Opinion, 32(1), 123-131. [More Information]
  • Huang, W., Castelino, R., Peterson, G. (2016). Lactic acidosis and the relationship with metformin usage: Case reports. Medicine, 95(46), 1-5. [More Information]
  • Bernal, D., Bereznicki, L., Chalmers, L., Castelino, R., Thompson, A., Davidson, P., Peterson, G. (2016). Medication Adherence Following Acute Coronary Syndrome: Does One Size Fit All? American Journal of Cardiovascular Drugs, 16(1), 9-17. [More Information]
  • Ghimire, S., Peterson, G., Castelino, R., Jose, M., Zaidi, S. (2016). Medication Regimen Complexity and Adherence in Haemodialysis Patients: An Exploratory Study. American Journal of Nephrology, 43(5), 318-324. [More Information]
  • Peterson, G., Huang, W., Castelino, R. (2016). Metformin: an old drug with clinical value and safety in old patients. Australian Pharmacist, July, 36-38.
  • Castelino, R., Peterson, G. (2016). Prescribing of metformin based on estimated GFR rather than serum creatinine expands the eligible population and is likely safe. Evidence-Based Medicine, 21(2), 68-68. [More Information]
  • Nishtala, P., Castelino, R., Peterson, G., Hannan, P., Salahudeen, M. (2016). Residential medication management reviews of antithrombotic therapy in aged care residents with atrial fibrillation: Assessment of stroke and bleeding risk. Journal Of Clinical Pharmacy And Therapeutics, 41(3), 279-284. [More Information]
  • Robiyanto, R., Zaidi, S., Shastri, M., Castelino, R., Troy Wanandy, S., Jose, M., Patel, R. (2016). Stability of tigecycline in different types of peritoneal dialysis solutions. Peritoneal Dialysis International, 36(4), 410-414. [More Information]

2015

  • Huang, W., Castelino, R., Peterson, G. (2015). Adverse event notifications implicating metformin with lactic acidosis in Australia. Journal of Diabetes and Its Complications, 29(8), 1261-1265. [More Information]
  • Huang, W., Peterson, G., Zaidi, S., Castelino, R. (2015). Metformin utilisation in Australian community and aged care settings. Diabetes Research and Clinical Practice, 108(2), 336-341. [More Information]
  • Ghimire, S., Castelino, R., Lioufas, N., Peterson, G., Zaidi, S. (2015). Nonadherence to medication therapy in haemodialysis patients: A systematic review. PloS One, 10(12), 1-19. [More Information]
  • Khanal, A., Peterson, G., Castelino, R., Jose, M. (2015). Potentially Inappropriate Prescribing of Renally Cleared Drugs in Elderly Patients in Community and Aged Care Settings. Drugs and Aging, 32(5), 391-400. [More Information]
  • Doody, H., Peterson, G., Watson, D., Castelino, R. (2015). Retrospective evaluation of potentially inappropriate prescribing in hospitalized patients with renal impairment. Current Medical Research and Opinion, 31(3), 525-535. [More Information]

2014

  • Bernal, D., Chalmers, L., Bereznicki, L., Castelino, R., Davidson, P., Peterson, G. (2014). An online person-centered education package for pharmacists delivering a home medication review service to patients following acute coronary syndromes. European Journal for Person Centered Healthcare, 2(3), 408-415. [More Information]
  • Khanal, A., Castelino, R., Peterson, G., Jose, M. (2014). Dose adjustment guidelines for medications in patients with renal impairment: How consistent are drug information sources? Internal Medicine Journal, 44(1), 77-85. [More Information]
  • Gheewala, P., Peterson, G., Curtain, C., Nishtala, P., Hannan, P., Castelino, R. (2014). Impact of the Pharmacist Medication Review Services on Drug-Related Problems and Potentially Inappropriate Prescribing of Renally Cleared Medications in Residents of Aged Care Facilities. Drugs and Aging, 31(11), 825-835. [More Information]
  • Huang, W., Castelino, R., Peterson, G. (2014). Metformin usage in type 2 diabetes mellitus: Are safety guidelines adhered to? Internal Medicine Journal, 44(3), 266-272. [More Information]
  • Khanal, A., Peterson, G., Castelino, R., Jose, M. (2014). Renal drug dosing recommendations: Evaluation of product information for brands of the same drug. Internal Medicine Journal, 44(6), 591-596. [More Information]

2013

  • Castelino, R., Bereznicki, L. (2013). How to read and interpret clinical trials (part 2). Australian Pharmacist, 32(10), 68-69.
  • Castelino, R., Bereznicki, L. (2013). The basics of evidence-based medicine. Australian Pharmacist, 32(2), 72-74.
  • Castelino, R., Bereznicki, L. (2013). Understanding non-randomised study designs. Australian Pharmacist, 32(6), 63-64.
  • Bereznicki, L., Castelino, R. (2013). Understanding randomised controlled trials. Australian Pharmacist, 32(4), 71-72.
  • Bereznicki, L., Castelino, R. (2013). Understanding systematic reviews. Australian Pharmacist, 32(8), 68-69.

2012

  • Bernal, D., Stafford, L., Bereznicki, L., Castelino, R., Davidson, P., Peterson, G. (2012). Home medicines reviews following acute coronary syndrome: Study protocol for a randomized controlled trial. Trials, 13(30), 1-17. [More Information]

2011

  • Castelino, R., Bajorek, B., Chen, T. (2011). Are interventions recommended by pharmacists during Home Medicines Review evidence-based? Journal of Evaluation in Clinical Practice, 17(1), 104-110. [More Information]
  • Castelino, R., Sathvik, B., Parthasarathi, G., Gurudev, K., Shetty, M., Narahari, M. (2011). Prevalence of medication-related problems among patients with renal compromise in an Indian hospital. Journal Of Clinical Pharmacy And Therapeutics, 36(4), 481-487. [More Information]

2010

  • Castelino, R., Hilmer, S., Bajorek, B., Nishtala, S., Chen, T. (2010). Drug Burden Index and potentially inappropriate medications in community-dwelling older people: the impact of Home Medicines Review. Drugs and Aging, 27(2), 135-148. [More Information]
  • Castelino, R., Bajorek, B., Chen, T. (2010). Retrospective Evaluation of Home Medicines Review by Pharmacists in Older Australian Patients Using the Medication Appropriateness Index. The Annals of Pharmacotherapy, 44(12), 1922-1929. [More Information]
  • Castelino, R., Chen, T., Guddattu, V., Bajorek, B. (2010). Use of evidence-based therapy for the prevention of cardiovascular events among older people. Evaluation and the Health Professions, 33(3), 276-301. [More Information]

2009

  • Castelino, R., Bajorek, B., Chen, T. (2009). Targeting Suboptimal Prescribing in the Elderly: A Review of the Impact of Pharmacy Services. The Annals of Pharmacotherapy, 43(6), 1096-1106. [More Information]

For support on your academic profile contact .